ArticleMedicine2022

Chemotherapy versus alectinib for the treatment of crizotinib-pretreated ALK-positive patients with non small cell lung cancer: A protocol for systematic review and meta-analysis.

Ting Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.